BRPI1009900A2 - métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores - Google Patents

métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores

Info

Publication number
BRPI1009900A2
BRPI1009900A2 BRPI1009900A BRPI1009900A BRPI1009900A2 BR PI1009900 A2 BRPI1009900 A2 BR PI1009900A2 BR PI1009900 A BRPI1009900 A BR PI1009900A BR PI1009900 A BRPI1009900 A BR PI1009900A BR PI1009900 A2 BRPI1009900 A2 BR PI1009900A2
Authority
BR
Brazil
Prior art keywords
dioxo
diazabicyclo
precursors
ethyl
preparation
Prior art date
Application number
BRPI1009900A
Other languages
English (en)
Inventor
Giuseppe Angelo Miraglia
Jignesh Patel
Luisa Borrello
Michael Joseph O Neill
Rosa Norato
Stefania Sapienza
Thomas Gerard Cullen
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI1009900A2 publication Critical patent/BRPI1009900A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI1009900A 2009-03-19 2010-03-19 métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores BRPI1009900A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16151309P 2009-03-19 2009-03-19
PCT/US2010/027908 WO2010108063A1 (en) 2009-03-19 2010-03-19 Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid and precursors thereof

Publications (1)

Publication Number Publication Date
BRPI1009900A2 true BRPI1009900A2 (pt) 2016-03-15

Family

ID=42227623

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009900A BRPI1009900A2 (pt) 2009-03-19 2010-03-19 métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores

Country Status (12)

Country Link
US (2) US20120116074A1 (pt)
EP (1) EP2408790A1 (pt)
JP (1) JP2012521352A (pt)
KR (1) KR20110139274A (pt)
CN (1) CN102356087A (pt)
AR (1) AR075900A1 (pt)
AU (1) AU2010226479A1 (pt)
BR (1) BRPI1009900A2 (pt)
CA (1) CA2754390A1 (pt)
MX (1) MX2011009716A (pt)
WO (1) WO2010108063A1 (pt)
ZA (1) ZA201107412B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2496125C2 (ru) * 2008-02-25 2013-10-20 Конинклейке Филипс Электроникс Н.В. Передающая среда для детекторов излучения, расположенная в изометрической плоскости
WO2010121133A2 (en) * 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
KR101474063B1 (ko) 2012-05-23 2014-12-19 동국대학교 산학협력단 피브린 표적 펩타이드 서열이 결합된 글라이콜 키토산-금 나노입자를 포함하는 혈전 탐지용 ct 조영제
US20170050989A1 (en) * 2013-12-03 2017-02-23 The General Hospital Corporation Molecular Imaging Probes
WO2018204872A2 (en) 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
AU2018261888B2 (en) 2017-05-05 2022-06-30 Centre For Probe Development And Commercialization Pharmacokinetic enhancements of bifunctional chelates and uses thereof
CA3128891A1 (en) 2019-12-09 2021-06-17 Sino Canada Health Institute Inc. Method for monitoring pet readout positions using mri fiducials
AU2022282449A1 (en) * 2021-05-27 2023-11-30 Fusion Pharmaceuticals Inc. 2,6-dichlorophenyl ester compounds and use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH584232A5 (pt) * 1973-07-26 1977-01-31 Ciba Geigy Ag
US4899755A (en) 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US5021556A (en) 1987-07-22 1991-06-04 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
US5075099A (en) 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5364613A (en) 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
EP0489869B1 (en) 1989-08-28 1998-11-11 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic nmr imaging
US5367080A (en) 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5168103A (en) 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
JP2774378B2 (ja) 1991-02-08 1998-07-09 ダイアテク,インコーポレイテッド 映像用テクネチウム−99m標識化ポリペプチド
US5849261A (en) 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5965107A (en) 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
JP3812680B2 (ja) 1994-03-16 2006-08-23 マリンクロッド・インコーポレイテッド 放射性医薬用途のペプチド類およびタンパク質類の安定化
US5582814A (en) 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
TW319763B (pt) 1995-02-01 1997-11-11 Epix Medical Inc
US5672877A (en) 1996-03-27 1997-09-30 Adac Laboratories Coregistration of multi-modality data in a medical imaging system
KR20060025233A (ko) 1996-04-01 2006-03-20 에픽스 메디칼, 인코포레이티드 생체활성화 진단용 영상 콘트라스트 제제
ATE314097T1 (de) 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
US5919967A (en) 1997-04-11 1999-07-06 Epix Medical, Inc. Process for synthesizing phosphodiesters
US5886142A (en) 1997-05-20 1999-03-23 Thomas Jefferson University Radiolabeled thrombus imaging agents
BR9811807A (pt) * 1997-08-01 2000-08-15 American Home Prod Processo para a preparação de ácido [2-(8,9)-dioxo-2,6-diazabiciclo-[5.2.0]-non-1(7)-en-2-il)-etil] fosfÈnico
ES2206996T3 (es) 1997-10-02 2004-05-16 Epix Medical Inc Metodo de formacion de imagenes para diagnostico con contraste mejorado para monitorizar terapias de intervencion.
EP1203026A4 (en) 1999-07-29 2005-03-16 Dyax Corp BINDING CENTERS FOR FIBRIN
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
US6549798B2 (en) 2001-02-07 2003-04-15 Epix Medical, Inc. Magnetic resonance angiography data
TWI284539B (en) 2001-07-30 2007-08-01 Epix Pharm Inc A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
DE10141186A1 (de) 2001-08-22 2003-03-20 Siemens Ag Einrichtung zum Bearbeiten von Bildern, insbesondere medizinischen Bildern
UA78529C2 (en) 2001-10-10 2007-04-10 Wyeth Corp Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US6898331B2 (en) 2002-08-28 2005-05-24 Bae Systems Aircraft Controls, Inc. Image fusion system and method
CA2526760A1 (en) 2003-05-23 2005-01-06 Epix Pharmaceuticals, Inc. Optically pure and enriched isomers of chelating ligands and contrast agents
CN100418585C (zh) 2003-07-24 2008-09-17 伯拉考成像股份公司 稳定的放射性药物组合物及制备方法
TW200514775A (en) 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
WO2007047608A2 (en) 2005-10-14 2007-04-26 Epix Pharmaceuticals, Inc. Fibrin targeted therapeutics
EP2111237B1 (en) * 2006-12-11 2015-03-18 BRACCO IMAGING S.p.A. Fibrin-binding peptides and conjugates thereof
US20090061024A1 (en) 2007-08-27 2009-03-05 Wyeth Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect

Also Published As

Publication number Publication date
MX2011009716A (es) 2011-10-17
CA2754390A1 (en) 2010-09-23
EP2408790A1 (en) 2012-01-25
KR20110139274A (ko) 2011-12-28
WO2010108063A1 (en) 2010-09-23
US20120077958A1 (en) 2012-03-29
AR075900A1 (es) 2011-05-04
CN102356087A (zh) 2012-02-15
US20120116074A1 (en) 2012-05-10
ZA201107412B (en) 2012-07-25
JP2012521352A (ja) 2012-09-13
US9200017B2 (en) 2015-12-01
AU2010226479A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
BR112012008164A2 (pt) método para a preparação de ácido 2,5-furanodicarbloxílico e seus ésteres
IL192242A0 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
DK2350075T3 (da) Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer
EP2049463A4 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CYCLOPROPYLAMINES
ZA201107412B (en) Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof
WO2011012816A3 (fr) Formulation pharmaceutique
ZA200903533B (en) Process for the preparation of rosuvastatin
IL196697A (en) Use of 4 Hydroxy-Alpha-Phenyl Butyl Nitron or its Derivatives to Prepare a Cure for Sensory-Neural Hearing Loss
IL199792A0 (en) Improved process for the preparation of oxidized phospholipids
IL203051A (en) Use of alpha-ketoglutarate for drug preparation
EP1937633B8 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
DE112007001669A5 (de) Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung
EP2621284A4 (en) Method for preparation of an aqueous glyphosate concentrate
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
ZA200809171B (en) Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group
BRPI1006758A2 (pt) compostos fosfocálcicos dopados com gálio, processos em estado sólido e em solução para a fabricação de um composto fosfocálcico dopado com gálio e uso de um composto fosfocálcico dopado com gálio
IL210214A0 (en) Process for the preparation of substituted pyrimidine derivatives
BRPI0815110A2 (pt) Sistemas de distribuição para soulubilização de ingredientes farmaceuticamente ativos insolúveis em água
FR2927900B1 (fr) Procede de preparation d'alpha-aminoacetals optiquement actifs.
SI2170920T1 (sl) Stabilne soli s-adenozilmetionina in postopek za pripravo le-teh
IL206032A0 (en) Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
BRPI0821426A2 (pt) Compostos de n-fenil-imidazol[1,2-a]piridina-2-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica.
PL2230916T3 (pl) Formulacje chwastobójcze dla soli trietanoloaminowych glifosatu
WO2007138462A3 (en) Aqueous oral formulations of risperidone
GB2464854B (en) Process for the preparation of risperidone

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired